Pharmacokinetic parameters of doxorubicin metabolites in plasma of control versus LPS-treated mice following administration of doxorubicin at a 5 mg/kg i.v. dose (mean ± S.E.)
↵* Significantly different from controls, p < 0.05 (Z test)